Pregnant women to receive Moderna COVID-19 vaccine in clinical trial

According to a posting on ClinicalTrials.gov, Moderna will begin studying its COVID-19 vaccine in pregnant women, Fox Business reported.

The trial aims to enroll about 1000 participants over the age of 18 who will be studied over a 21-month period.

The study will measure the number of participants who have infants with suspected major and minor congenital malformations, the number with any pregnancy complications, the number with any pregnancy outcomes and the number with infant outcomes. 

It is estimated that the study will start July 22, with an estimated primary completion date of December 9, 2023. 

The Centers for Disease Control and Prevention currently states that pregnant women can receive a COVID-19 vaccine, but clinical trials specifically studying the shots among this population were not done when the FDA granted any of the vaccines' emergency use authorization.